BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu YH, Deng JL, Wang G, Zhu YS. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications. Cancer Lett 2019;464:37-55. [PMID: 31465841 DOI: 10.1016/j.canlet.2019.08.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang J, Xin C, Yin G, Li J. Taraxasterol suppresses the proliferation and tumor growth of prostate cancer cells through the FGFR2-PI3K/AKT signaling pathway.. [DOI: 10.21203/rs.3.rs-2437423/v1] [Reference Citation Analysis]
2 Xin S, Mao J, Cui K, Li Q, Chen L, Li Q, Tu B, Liu X, Wang T, Wang S, Liu J, Song X, Song W. A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma. Front Mol Biosci 2022;9:974722. [DOI: 10.3389/fmolb.2022.974722] [Reference Citation Analysis]
3 Berenguer CV, Pereira F, Pereira JAM, Câmara JS. Volatilomics: An Emerging and Promising Avenue for the Detection of Potential Prostate Cancer Biomarkers. Cancers 2022;14:3982. [DOI: 10.3390/cancers14163982] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Snyder M, Iraola-guzmán S, Saus E, Gabaldón T. Discovery and Validation of Clinically Relevant Long Non-Coding RNAs in Colorectal Cancer. Cancers 2022;14:3866. [DOI: 10.3390/cancers14163866] [Reference Citation Analysis]
5 Shen D, Peng H, Xia C, Deng Z, Tong X, Wang G, Qian K. The Role of Long Non-Coding RNAs in Epithelial-Mesenchymal Transition-Related Signaling Pathways in Prostate Cancer. Front Mol Biosci 2022;9:939070. [DOI: 10.3389/fmolb.2022.939070] [Reference Citation Analysis]
6 Tang L, Li W, Xu H, Zheng X, Qiu S, He W, Wei Q, Ai J, Yang L, Liu J. Mutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer. Front Oncol 2022;12:876531. [DOI: 10.3389/fonc.2022.876531] [Reference Citation Analysis]
7 You X, Wu Y, Li Q, Sheng W, Zhou Q, Fu W. Astragalus–Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy. Front Pharmacol 2022;13:895696. [DOI: 10.3389/fphar.2022.895696] [Reference Citation Analysis]
8 Kong P, Zhang L, Zhang Z, Feng K, Sang Y, Duan X, Liu C, Sun T, Tao Z, Liu W. Emerging Proteins in CRPC: Functional Roles and Clinical Implications. Front Oncol 2022;12:873876. [PMID: 35756667 DOI: 10.3389/fonc.2022.873876] [Reference Citation Analysis]
9 Xin S, Deng Y, Mao J, Wang T, Liu J, Wang S, Song X, Song W, Liu X. Characterization of 7-Methylguanosine Identified Biochemical Recurrence and Tumor Immune Microenvironment in Prostate Cancer. Front Oncol 2022;12:900203. [PMID: 35677157 DOI: 10.3389/fonc.2022.900203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xing Z, Li S, Xing J, Yu G, Wang G, Liu Z. Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis. Lab Invest 2022;102:602-12. [PMID: 35152275 DOI: 10.1038/s41374-022-00736-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Alarcón-zendejas AP, Scavuzzo A, Jiménez-ríos MA, Álvarez-gómez RM, Montiel-manríquez R, Castro-hernández C, Jiménez-dávila MA, Pérez-montiel D, González-barrios R, Jiménez-trejo F, Arriaga-canon C, Herrera LA. The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches. Prostate Cancer Prostatic Dis. [DOI: 10.1038/s41391-022-00537-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Zhu J, Guan J, Ji X, Song Y, Xu X, Wang Q, Zhang Q, Guo R, Wang R, Zhang R. A two-phase comprehensive NSCLC prognostic study identifies lncRNAs with significant main effect and interaction. Mol Genet Genomics 2022. [PMID: 35218396 DOI: 10.1007/s00438-022-01869-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Al-e-ahmad A, Neamati N, Moudi E, Younesi S, Parsian H. Noncoding RNAs in prostate cancer patients. Clinical Applications of Non-Coding RNAs in Cancer 2022. [DOI: 10.1016/b978-0-12-824550-7.00002-3] [Reference Citation Analysis]
14 Ruiz-Manriquez LM, Estrada-Meza C, Benavides-Aguilar JA, Ledesma-Pacheco SJ, Torres-Copado A, Serrano-Cano FI, Bandyopadhyay A, Pathak S, Chakraborty S, Srivastava A, Sharma A, Paul S. Phytochemicals mediated modulation of microRNAs and long non-coding RNAs in cancer prevention and therapy. Phytother Res 2021. [PMID: 34932245 DOI: 10.1002/ptr.7338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Zhang H, Wang M, He Y, Deng T, Liu R, Wang W, Zhu K, Bai M, Ning T, Yang H, Liu Y, Wang J, Ba Y. Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cells. Cell Death Dis 2021;12:1116. [PMID: 34845198 DOI: 10.1038/s41419-021-04406-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
16 Cagle P, Qi Q, Niture S, Kumar D. KCNQ1OT1: An Oncogenic Long Noncoding RNA. Biomolecules 2021;11:1602. [PMID: 34827600 DOI: 10.3390/biom11111602] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
17 Sun JY, Ni MM. Long non-coding RNA HEIH: a novel tumor activator in multiple cancers. Cancer Cell Int 2021;21:558. [PMID: 34689775 DOI: 10.1186/s12935-021-02272-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Mirzakhani K, Kallenbach J, Rasa SMM, Ribaudo F, Ungelenk M, Ehsani M, Gong W, Gassler N, Leeder M, Grimm MO, Neri F, Baniahmad A. The androgen receptor-lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells. Oncogene 2021. [PMID: 34667276 DOI: 10.1038/s41388-021-02060-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mao C, Ding Y, Xu N. Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications. Mol Cell Biochem 2021. [PMID: 34655417 DOI: 10.1007/s11010-021-04273-4] [Reference Citation Analysis]
20 Capik O, Sanli F, Kurt A, Ceylan O, Suer I, Kaya M, Ittmann M, Karatas OF. CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis. Prostate Cancer Prostatic Dis 2021;24:891-902. [PMID: 33753875 DOI: 10.1038/s41391-021-00353-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Guo M, Li D, Feng Y, Li M, Yang B. Adipose-derived stem cell-derived extracellular vesicles inhibit neuroblastoma growth by regulating GABBR1 activity through LINC00622-mediated transcription factor AR. J Leukoc Biol 2021. [PMID: 34448502 DOI: 10.1002/JLB.1MIA0321-164R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Samaržija I. Site-Specific and Common Prostate Cancer Metastasis Genes as Suggested by Meta-Analysis of Gene Expression Data. Life (Basel) 2021;11:636. [PMID: 34209195 DOI: 10.3390/life11070636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Li Y, Rui X, Chen D, Xuan H, Yang H, Meng X. LncRNA AWPPH as a prognostic predictor in human cancers in Chinese population: evidence from meta-analysis. Biosci Rep 2021;41:BSR20210012. [PMID: 34042153 DOI: 10.1042/BSR20210012] [Reference Citation Analysis]
24 Zhang Y, Wang C, Zou X, Tian X, Hu J, Zhang CY. Simultaneous Enzyme-Free Detection of Multiple Long Noncoding RNAs in Cancer Cells at Single-Molecule/Particle Level. Nano Lett 2021;21:4193-201. [PMID: 33949866 DOI: 10.1021/acs.nanolett.0c05137] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
25 Zhang L, Li Y, Wang X, Ping Y, Wang D, Cao Y, Dai Y, Liu W, Tao Z. Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate Adenocarcinoma. J Cancer 2021;12:3626-47. [PMID: 33995639 DOI: 10.7150/jca.52170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Sur S, Ray RB. Emerging role of lncRNA ELDR in development and cancer. FEBS J 2021. [PMID: 33860640 DOI: 10.1111/febs.15876] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
27 Cui Z, Gao H, Yan N, Dai Y, Wang H, Wang M, Wang J, Zhang D, Sun P, Qi T, Wang Q, Kang W, Jin X. LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis. Aging (Albany NY) 2021;13:12113-28. [PMID: 33848262 DOI: 10.18632/aging.202919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 Sun Y, Chen L, Zhang Y, Zhang J, Tiwari SR. Genome-wide Identification of Differently Expressed lncRNAs, mRNAs, and circRNAs in Patients with Osteoarthritis. CBIO 2021;15:1222-30. [DOI: 10.2174/1574893615999200706002907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Du L, Gao Y. PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer. J Transl Med 2021;19:12. [PMID: 33407592 DOI: 10.1186/s12967-020-02572-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
30 Upadhyay N, Tilekar K, Hess JD, Pokrovsky VS, Aguilera RJ, C S R. Benefits and pitfalls: Epigenetic modulators in prostate cancer intervention. Current Research in Chemical Biology 2021;1:100006. [DOI: 10.1016/j.crchbi.2021.100006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Fu DJ, Liu SM, Li FH, Yang JJ, Li J. Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors. J Enzyme Inhib Med Chem 2020;35:1050-9. [PMID: 32299262 DOI: 10.1080/14756366.2020.1753721] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
32 Lu K, Yu M, Chen Y. Non-coding RNAs regulating androgen receptor signaling pathways in prostate cancer. Clin Chim Acta 2021;513:57-63. [PMID: 33309734 DOI: 10.1016/j.cca.2020.11.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Qian Y, Shi L, Luo Z. Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy. Front Med (Lausanne) 2020;7:612393. [PMID: 33330574 DOI: 10.3389/fmed.2020.612393] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 14.0] [Reference Citation Analysis]
34 Xu G, Xu WY, Xiao Y, Jin B, Du SD, Mao YL, Zhang ZT. The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma. Cancer Cell Int 2020;20:496. [PMID: 33061848 DOI: 10.1186/s12935-020-01581-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
35 Fan H, Hou J, Liu S, Xiao Z, Cui J. Long Non-Coding RNA DARS-AS1 Contributes to Prostate Cancer Progression Through Regulating the MicroRNA-628-5p/MTDH Axis. Cancer Manag Res 2020;12:8363-77. [PMID: 32982430 DOI: 10.2147/CMAR.S271021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
36 Wu S, Ding L, Xu H, Gao J, Shao Y, Zhang S, Wei Z. The Long Non-Coding RNA IDH1-AS1 Promotes Prostate Cancer Progression by Enhancing IDH1 Enzyme Activity. Onco Targets Ther 2020;13:7897-906. [PMID: 32884284 DOI: 10.2147/OTT.S251915] [Reference Citation Analysis]
37 Wu J, Li R, Li L, Gu Y, Zhan H, Zhou C, Zhong C. MYC-activated lncRNA HNF1A-AS1 overexpression facilitates glioma progression via cooperating with miR-32-5p/SOX4 axis. Cancer Med 2020;9:6387-98. [PMID: 33448691 DOI: 10.1002/cam4.3186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
38 Wu H, Tian X, Zhu C. Knockdown of lncRNA PVT1 inhibits prostate cancer progression in vitro and in vivo by the suppression of KIF23 through stimulating miR-15a-5p. Cancer Cell Int 2020;20:283. [PMID: 32624708 DOI: 10.1186/s12935-020-01363-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
39 Wang X, Zhang J, Liu X, Wei B, Zhan L. Long noncoding RNAs in endometriosis: Biological functions, expressions, and mechanisms. J Cell Physiol 2021;236:6-14. [PMID: 32506425 DOI: 10.1002/jcp.29847] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
40 Zhang J, Rui Y, Gao M, Wang L, Yan BC. Expression of Long Non-coding RNA RGD1566344 in the Brain Cortex of Male Mice After Focal Cerebral Ischemia-Reperfusion and the Neuroprotective Effect of a Non-coding RNA RGD1566344 Inhibitor. Cell Mol Neurobiol 2021;41:705-16. [PMID: 32424772 DOI: 10.1007/s10571-020-00877-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Nanni S, Bacci L, Aiello A, Re A, Salis C, Grassi C, Pontecorvi A, Gaetano C, Farsetti A. Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer. Mol Cell Endocrinol 2020;511:110864. [PMID: 32413384 DOI: 10.1016/j.mce.2020.110864] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
42 Feng X, Yang S, Zhou S, Deng S, Xie Y. Long non-coding RNA DDX11-AS1 promotes non-small cell lung cancer development via regulating PI3K/AKT signalling. Clin Exp Pharmacol Physiol 2020;47:1622-31. [PMID: 32298476 DOI: 10.1111/1440-1681.13325] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]